Unique ID issued by UMIN | UMIN000022290 |
---|---|
Receipt number | R000025268 |
Scientific Title | Comparison of acid inhibition attained by Vonoprazan with or without Lafutidine. |
Date of disclosure of the study information | 2016/07/01 |
Last modified on | 2017/05/23 16:06:47 |
Comparison of acid inhibition attained by Vonoprazan with or without Lafutidine.
Comparison of acid inhibition attained by Vonoprazan with or without Lafutidine.
Comparison of acid inhibition attained by Vonoprazan with or without Lafutidine.
Comparison of acid inhibition attained by Vonoprazan with or without Lafutidine.
Japan |
Reflux esophagitis
Gastroenterology |
Others
NO
The aim of this study is to compare acid inhibitory effect of Vonoprazan and that with Lafutidine.
Pharmacodynamics
Confirmatory
Explanatory
Not applicable
The primary outcome is acid inhibition with the three regimens as assessed by 24-hour intragastric pH monitoring on Day7 in each regimen.
Interventional
Cross-over
Non-randomized
Open -no one is blinded
Active
6
Treatment
Medicine |
There are three regimens as follows; (1) Vonoprazan 20mg once daily for 7 days, (2) Vonoprazan 10mg once daily for 7 days, (3) Vonoprazan 10mg and Lafutidine 10mg once daily for 7 days. Subujects receive the three different regimens in a crossover manner. The order of the four regimens is randomized as interventions 1-24. Interventions 16-24 are mentioned in other related information, because of lack of the space.
A clinical research coordinator manages the dosing schedule of each subject. The washout period between the different regimens is at least 2 weeks. In each regimen, 24-h intragastric pH monitoring is performed on Day7.
Interventions 1; regimen (1), washout (at least 2 weeks), regimen (2), washout (at least 2 weeks), and regimen (3).
Interventions 2; regimen (1), washout (at least 2 weeks), regimen (3), washout (at least 2 weeks), and regimen (2).
Interventions 3; regimen (2), washout (at least 2 weeks), regimen (1), washout (at least 2 weeks), and regimen (3).
Interventions 4; regimen (2), washout (at least 2 weeks), regimen (3), washout (at least 2 weeks), and regimen (1).
Interventions 5; regimen (3), washout (at least 2 weeks), regimen (1), washout (at least 2 weeks), and regimen (2).
Interventions 6; regimen (3), washout (at least 2 weeks), regimen (2), washout (at least 2 weeks), and regimen (1).
18 | years-old | <= |
Not applicable |
Male and Female
Healthy Japanese men and women.
Exclusion criteria are any underlying disease, smoking habit, past or present H.pylori infection, and habitual use of any medicine.
30
1st name | |
Middle name | |
Last name | Takahiro Suzuki |
Hamamatsu University School of Medicine
First Department of Medicine
1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, Japan
053-435-2111
takahr99@hama-med.ac.jp
1st name | |
Middle name | |
Last name | Takahisa Furuta |
Hamamatsu University School of Medicine
Center for Clinical Research
1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, Japan
053-435-2261
furuta@hama-med.ac.jp
First Department of Medicine and Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan
First Department of Medicine and Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan
Other
Japan
NO
浜松医科大学(静岡県)
2016 | Year | 07 | Month | 01 | Day |
Unpublished
Completed
2016 | Year | 05 | Month | 12 | Day |
2016 | Year | 07 | Month | 01 | Day |
2017 | Year | 02 | Month | 24 | Day |
2017 | Year | 02 | Month | 24 | Day |
2017 | Year | 02 | Month | 24 | Day |
2017 | Year | 06 | Month | 30 | Day |
2016 | Year | 05 | Month | 12 | Day |
2017 | Year | 05 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025268